SPECIAL ORIENTATION TECHNIQUE

• Document Type: CREST
• Collection: STARGATE
• Document Number (FOIA) /ESDN (CREST): CIA-RDP96-00788R001500110024-9
• Release Decision: RIFPUB
• Original Classification: S
• Document Page Count: 6
• Document Creation Date: November 4, 2016
• Document Release Date: September 6, 2000
• Sequence Number: 24
• Publication Date: February 16, 1983
• Content Type: STATEMENT

pproved For Release 20'K/X107:'C1AMRDP96-00788R001500110024-9
DEPARTMENT OF THE ARMY
US ARMY INTELLIGENCE AND SECURITY COMMAND
FORT GEORGE G. MEADE, MARYLAND 20755
Cebruary 16 1983
SUBJECT: Special Orientation Technique (U)
Dr. Harold C. Puthoff
SRI International
333 Ravenswood Avenue
Menlo Park, California 94025
(U) Reference contract DA Kf- 27-B3-C-0018.
(U) Attached is the statement of work to be performed under
the referenced contract.
(S/CL-1/NOFORN) Also attached is the Security Classification
Guide which has been developed for INSCOM Project CENTER LANE.
I solicit your review and comments concerning the guide.
(U) Correspondence should now be forwarded to the address
listed in paragraph 5 of the Classification Guide.
J
Robert J. Jachim
LTC, MI
Project Manager
CLASSIFIED BY: CG INSCOM
DI CL: Originating Agency's
Determination Required
Approved For Release 2 0788R001500110024-9
 Approved For Release 2001/04/02 : P96-00788 R001500110024-9
STATEMENT OF WORK - SPECIAL ORIENTATION TECHNIQUE (U)
].. (U) GENERAL
1.1 (S/CL-3/NOFORN) The objective of this effort is to investigate a
particular aspect of the psychoenergetic phenomena known as remote viewing
that has potential military intelligence application. Coordinate Remote
Viewing (CRV) is a staged technique which utilizes coordinates to
facilitate acquisition of a remote viewing target.
1.2 (S/CL-3/NOFORN) Major goals are the determination if CRV technology
can be successfully transferred to INSCOM personnel with a corresponding
increase in the reliability of a remote viewer.
2. (U) SPECIFIC TASK
2.1 (S/CL-3/NOFORN) Train army personnel in CRV Stages III and IV.
2.1..1. (S/CL-3/NOFORN) Initiate training at the highest skill level
(CRV Stage) of the trainee.
2.1.2 (S/CL-3/NOFORN) Training for each CRV stage will normally be
divided into three two week working sessions. The session dates will be
mutually agreed to by SRI and INSCOM.
2.1.3 (S/CL-3/NOFORN) After successful completion of CRV Stage III,
schedule the trainee to begin CRV Stage IV.
2.2 (U) Determine the potential of the trainee for further training.
3. (U) SECURITY
Military security requirements in the performance of this contract shall be
maintained in accordance with DD Form 254 attached hereto. The highest
classification involved in the performance of this contract is SECRET-
NO FOREIGN DISSEMINATION.
4. (U) DELIVERABLES: The contractor will provide the following.
4.1. (S/CL-3/NOFORN) State-of-the-Art CRV training.
4.2 (U) Progress report (2 copies): Written evaluation of trainee Ncj
progress at the completion of each two week working session.
CLASSIFIED BY: CG INSCOM
DECLASSIFY: Originating Agency's
Determination Required
Approved For Release 2001/04/02 : CIA-RDP96-00788R001500110024-9
 Approved For Release 2001/04/02 : CIA-RDP96-00788R001500110024-9
4.3 (U) Final Report:
4.3.1 (U) A final report, in three copies will be furnished within
30 days after completion of each training stage.
4.3.2 (U) Report will include a summary of the training presented;
an evaluation of the trainee's ability to understand the training; and a
summary of the trainee's accomplishments during the training period.
4.3.3 (S/CL-3/NOFORN) Report should also include an evaluation of the
trainee's future remote viewing capabilities, and a recommendation
concerning further training.
5. (S/CL-3/NOFORN) POST TRAINING ACCESS: After the completion of each CRU
training stage personnel involved in the training program will have
reasonable access to INSCOM personnel trained to assist in further
evaluation of CRV.
6. (U) SPECIAL REQUIREMENTS
6.l (U) Use of human subjects
(a) (U) The following definitions are used:
(1.) (U) At risk means that the human subject may be exposed to the
possibility of harm - physical, biological, psychological, sociological,
or other as a consequence of an act or omission that goes beyond the
application of those established and accepted methods or procedures which
are in his best interests, or that increases ordinary risks of daily life,
including the recognized risks inherent in his chosen occupation or field
of service. '
(2) (U) Human subject means any human being who, knowingly or
unknowingly, is subjected to an act or omission, whether at risk or not,
the object of which is to contribute to knowledge to be gained as a part
of work to be performed under the scope of this contract.
(b) (U) The contractor, before undertaking to perform any study
involving human subjects, whether at risk or not., shall insure that the
following minimum conditions are complied with:
(1) (U) The proposed study has been reviewed and approved by a
committee meeting the requirements set forth in Chapter 46 of Title 45 of
the Code of Federal Regulations.
(2) (U) The number of human subjects used will be kept to the
minimum number that will reasonably achieve the required results.
(3) (U) The study must be such as to contribute significantly to
scientific knowledge and have reasonable prospects of yielding important
results essential to an Army research program.
(4) (U) The study will be conducted only by persons possessing
Approved For Release 2001/04/02 : CIA-RDP96-00788R001500110024-9
2
 Approved For Release 2001/04/02 : CIA-RDP96-00788R001500110024-9
the requisite scientific qualifications. The highest degree of skill
and care will be required during all stages of study of persons who conduct
or assist in the study.
(5) (U) The human subject will be informed that at any time during
the course of` his participation he has the right to revoke his consent and
withdraw from participation without prejudice to himself.
(6) (U) Participation by subjects will be immediately terminated
if it subsequently appears that the risk to the subjects is significantly
greater than anticipated at the time review and approval was granted.
(7) (U) There shall be no greater intrusion into the privacy of
the human subject than is absolutely necessary for the conduct of the study
involved. Except for the submission of reports and other data required by
this contract, any information obtained about human subjects as a result of
participation shall be held as confidential as the law allows.
(8) (U) The study will be conducted so as to avoid all unnecessary
physical or mental suffering or injury.
(9) (U) No study will be conducted if there is any inherent reason
to believe that death or disabling injury is likely to occur. Sufficient
animal or laboratory experiments, or other evaluations, must have been
completed to give assurance of acceptable risks prior to the use of human
subjects.
(10) (U) The degree of risk to be taken will never exceed that which
is justified by the benefit to the subject and/or the humanitarian importance
of the knowledge to be gained.
(11) (U) A physician will be responsible for the medical care of
subjects. Even if not the project leader, the physician will have authority
to terminate the study at any time that he believes death, injury or harm
is likely to result.
(12) (U) Proper preparations will be made, and adequate facilities
provided to protect the subject against all foreseeable possibilities if
injury, disability or death. This includes but is not limited to
hospitalization and medical treatment as may be required. In addition, all
apparatus and instruments necessary to deal with likely emergency situations
will be available.
(13) (U) Human subjects will have no physical or mental conditions
which will make participation mote hazardous for them than it would be for
normal healthy persons, unless such condition is a necessary prerequisite for
the the particular study involved. In any such case, the use of human
subjects with such pre-existing conditions must have been specifically
described and justified in the scope of the work to be performed under this
contract.
Approved For Release 2001/04/02 : CIA-RDP96-00788R001500110024-9
3
 Approved For Release 2001/04/02 : CIA-RDP96-00788R001500110024-9
(14) (U) The scientifically qualified person conducting the study,
and each member of his research team, will be prepared to terminate the
subject's participation at any stage if he has reason to believe, in the
exercise of the good faith, superior skill, and careful judgement required
of him, that continuation is likely to result in injury, disability, or
death to the human subject.
(c) (Q) The contractor, before permitting any person to participate
as a human subject, whether at risk or not, shall insure that the following
minimum conditions are complied with:
(1) (U) Legally effective informed consent will be obtained
by adequate and appropriate methods in accordance with the provisions of
this clause.
(2) (U) All consent must be voluntary. It must be the knowing
consent of the individual or his legally authorized representative, so
situated as to be able to exercise free power of choice without there
having been any use of farce, fraud, deceit, duress, constraint, coercion,
or lawful or improper inducement. The elements of information necessary
to such consent include:
(i) (U) A fair explanation of the procedures to be followed, and
their purposes, including identification of any procedures which are
experimental.
(ii) (U) A description of any attendant discomforts or risks
reasonably to be anticipated.
(ii.i) (U) A description of any benefits reasonably to be
anticipated.
(iv) (U) A disclosure of any appropriate alternative procedures
that might be advantageous to the subject.
(v) (U) An offer to answer any questions concerning the procedure.
NO (U) An instruction that the subject is free to revoke his
consent and to discontinue participation at any time without prejudice to
himself.
(d) (U) Exculpatory language through which the subject is made to
waive, or appear to waive, any of his legal rights, including any release
from liability for negligence, is prohibited.
(e) (U) Prior consent by a subject or his legally authorized
representative shall be obtained in all cases. Such consent shall be in
writing whenever it is reasonably possible to do so. The consent form
may be read to the subject or his legally authorized representative, but
in any event he or his legally authorized representative must be given
adequate opportunity to read it and to ask questions they might have.
Approved For Release 2001/04/024: CIA-RDP96-00788R001500110024-9
 Approved For Release 2001/04/02 : CIA-RDP96-00788R001500110024-9
This consent form should then be signed by the subject or his legally
authorized representative and by a witness not directly involved in the
study. Oral consent may be used only when it has been specifically
described and justified in the scope of the work to be performed under this
contract or approved in writing by the contracting officer. When so
authorized and used, oral consent is subject to all the same standards as
apply to written consent, except that the signature of the subject or his
legally authorized representative is not required.
(f) (U) Prior to conduct of the study, the contractor shall
submit for approval to the contracting officer's representative a detailed
description of the means by which informed consent will be obtained, to
include any forms to be used. Upon completion of the study, the
contractor will submit to the contracting officer's representative a detailed
report demonstrating compliance with paragraph (c), to include copies of the
written consent if such was obtained.
(g) (U) The contractor shall not undertake to conduct either the
clinical pharmacology or clinical trails of an investigational drug unless
this contract contains the clause entitled "Clinical Study of Investigational
Drugs. "r
(h) (U) Prisoners of war will not be used under any circumstances.
6.2 (U) DoD Directive 5240.1-R governing experimentation on human
subjects will be followed by the contractor. Informed consent of all
subjects will be obtained in writing in accordance with the guidelines issued
by the Department of Health, Education and Welfare. All persons participating
as human subjects, as defined in paragraph 6.1 above shall be known to
possess the abilities and qualities which will be observed and analyzed
(hiring the conduct of this contract. '
Approved For Release 2001/04/02 : CIA-RDP96-00788R001500110024-9